1431468-36-8 (卡博替尼杂质2,N,\u200bN'-\u200bBis(4-\u200bfluorophenyl)\u200b-1,\u200b1-cyclopropanedicarbox\u200bamide)

卡博替尼杂质2;

N,N inverted exclamation mark -Bis(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;N,N'-Bis(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;SY272352;J3.598.035K;E70265;N,N'-Bis(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;N,N?-Bis(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;N,\u200bN'-\u200bBis(4-\u200bfluorophenyl)\u200b-1,\u200b1-cyclopropanedicarbox\u200bamide;MFCD32691165;CS-0166283;N,?N'-?Bis(4-?fluorophenyl)?-1,?1-cyclopropanedicarbox?amide;1-N,1-N'-bis(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;SCHEMBL12468984;1431468-36-8;N,N'-bis(4-fluorophenyl)cyclopropane-1,1-dicarboxamide? (Cabozantinib Impurity;N,N'-Bis(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; 1,1-Cyclopropanedicarboxamide, N,N'-bis(4-fluorophenyl)- (ACI); N,N'-Bis(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (ACI);1,1-Cyclopropanedicarboxamide, N,N'-bis(4-fluorophenyl)-;LB3XQ8TQ6J;

MFCD32691165

DDYIDQLZMNTOCH-UHFFFAOYSA-N

1S/C17H14F2N2O2/c18-11-1-5-13(6-2-11)20-15(22)17(9-10-17)16(23)21-14-7-3-12(19)4-8-14/h1-8H,9-10H2,(H,20,22)(H,21,23)

FC1C=CC(=CC=1)NC(C1(C(NC2C=CC(=CC=2)F)=O)CC1)=O